1-15767465-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_017556.4(FBLIM1):c.340C>T(p.Leu114Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000355 in 1,296,974 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_017556.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FBLIM1 | NM_017556.4 | c.340C>T | p.Leu114Phe | missense_variant | 4/9 | ENST00000375766.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FBLIM1 | ENST00000375766.8 | c.340C>T | p.Leu114Phe | missense_variant | 4/9 | 2 | NM_017556.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000735 AC: 1AN: 136108Hom.: 0 Cov.: 22
GnomAD3 exomes AF: 0.00000523 AC: 1AN: 191238Hom.: 0 AF XY: 0.00000948 AC XY: 1AN XY: 105516
GnomAD4 exome AF: 0.0000388 AC: 45AN: 1160866Hom.: 0 Cov.: 30 AF XY: 0.0000346 AC XY: 20AN XY: 577970
GnomAD4 genome AF: 0.00000735 AC: 1AN: 136108Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 65300
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 03, 2022 | The c.340C>T (p.L114F) alteration is located in exon 3 (coding exon 2) of the FBLIM1 gene. This alteration results from a C to T substitution at nucleotide position 340, causing the leucine (L) at amino acid position 114 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at